In-depth evaluation of Gly-Sar transport parameters as a function of culture time in the Caco-2 cell model

被引:28
作者
Bravo, SA
Nielsen, CU
Amstrup, J
Frokjaer, S
Brodin, B
机构
[1] Danish Univ Pharmaceut Sci, Dept Pharmaceut, DK-2100 Copenhagen, Denmark
[2] August Krogh Inst, Dept Zoophysiol, DK-2100 Copenhagen, Denmark
关键词
Caco-2 cell model; immunohistochemistry; Gly-Sar uptake; hPEPT1; characterization;
D O I
10.1016/S0928-0987(03)00205-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the present study was to investigate the influence of culture time on hPEPT1-mediated transport in Caco-2 cell monolayers. Peptide transport activity in Caco-2 cells grown in standard media and in a "rapid" 4-day model was first compared. The rapid 4-day Caco-2 cell model, cultured using a cocktail of growth factors and agonists, displayed lower peptide uptake capacity than Caco-2 cells grown for 4 days in conventional media, and was judged to be unsuitable for peptide transport studies. Peptide transport activity as well as monolayer integrity and tissue morphology were evaluated in the standard >21 days model as a function of the culture time. Peptide transport activity was studied using [C-14]-glycylsarcosine ([C-14]-Gly-Sar). Monolayer integrity was evaluated by transepithelial electrical resistance (TEER) measurements and [H-3]-mannitol permeabilities. Tissue morphology and hPEPT1 expression were studied using confocal laser scanning microscopy (CLSM) and conventional staining/immunostaining. Caco-2 cells grown in conventional media became confluent after 3-4 days. Mannitol permeability decreased from day 5 to 21 and TEER increased steadily until similar today 21. Apical hPEPT1 uptake activity appeared to be maximal in cells cultured for >21 days, whereas basolateral uptake reached a maximum already after 12 days in culture. In some of the passages studied, a secondary increase in hPEPT1 transport activity was observed in cells grown for >25 days. A large carrier-mediated transepithelial peptide flux component was evident from day 14. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:77 / 86
页数:10
相关论文
共 44 条
  • [1] Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir
    Balimane, PV
    Tamai, I
    Guo, AL
    Nakanishi, T
    Kitada, H
    Leibach, FH
    Tsuji, A
    Sinko, PJ
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 250 (02) : 246 - 251
  • [2] COMMON CHARACTERISTICS FOR NA+-DEPENDENT SUGAR-TRANSPORT IN CACO-2 CELLS AND HUMAN-FETAL COLON
    BLAIS, A
    BISSONNETTE, P
    BERTELOOT, A
    [J]. JOURNAL OF MEMBRANE BIOLOGY, 1987, 99 (02) : 113 - 125
  • [3] Decisive structural determinants for the interaction of proline derivatives with the intestinal H+/peptide symporter
    Brandsch, M
    Knütter, I
    Thunecke, F
    Hartrodt, B
    Born, I
    Börner, V
    Hirche, F
    Fischer, G
    Neubert, K
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 266 (02): : 502 - 508
  • [4] Intestinal transport of β-lactam antibiotics:: Analysis of the affinity at the H+/peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux
    Bretschneider, B
    Brandsch, M
    Neubert, R
    [J]. PHARMACEUTICAL RESEARCH, 1999, 16 (01) : 55 - 61
  • [5] BriskeAnderson MJ, 1997, P SOC EXP BIOL MED, V214, P248
  • [6] TRANSEPITHELIAL TRANSPORT OF CHOLYLTAURINE BY CACO-2 CELL MONOLAYERS IS SODIUM-DEPENDENT
    CHANDLER, CE
    ZACCARO, LM
    MOBERLY, JB
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (06): : G1118 - G1125
  • [7] A peptide prodrug approach for improving bisphosphonate oral absorption
    Ezra, A
    Hoffman, A
    Breuer, E
    Alferiev, IS
    Mönkkönen, J
    El Hanany-Rozen, N
    Weiss, G
    Stepensky, D
    Gati, I
    Cohen, H
    Törmälehto, S
    Amidon, GL
    Golomb, G
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (20) : 3641 - 3652
  • [8] PASSIVE AND CARRIER-MEDIATED INTESTINAL-ABSORPTION COMPONENTS OF 2 ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR PRODRUGS IN RATS - ENALAPRIL AND FOSINOPRIL
    FRIEDMAN, DI
    AMIDON, GL
    [J]. PHARMACEUTICAL RESEARCH, 1989, 6 (12) : 1043 - 1047
  • [9] INTESTINAL-ABSORPTION MECHANISM OF DIPEPTIDE ANGIOTENSIN CONVERTING ENZYME-INHIBITORS OF THE LYSYL-PROLINE TYPE - LISINOPRIL AND SQ-29,852
    FRIEDMAN, DI
    AMIDON, GL
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (12) : 995 - 998
  • [10] Valacycloviv: A substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2
    Ganapathy, ME
    Huang, W
    Wang, H
    Ganapathy, V
    Leibach, FH
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 246 (02) : 470 - 475